SCHEMBL6865805

SCHEMBL6865805

C=C(CCCCCCCCBr)C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TBXAS1 P24557 2/20 0.43
LMNA P02545 3/20 0.38
TSHR P16473 1/20 0.38
NFKB1 P19838 1/20 0.38
PMP22 Q01453 1/20 0.38
TET2 Q6N021 3/20 0.33
TET3 O43151 1/20 0.33
TET1 Q8NFU7 1/20 0.33
THRB P10828 1/20 0.33
FNTA P49354 1/20 0.33
FNTB P49356 1/20 0.33
PGGT1B P53609 1/20 0.33
MAPT P10636 2/20 0.32
L3MBTL1 Q9Y468 2/20 0.32
GRIK1 P39086 1/20 0.32
GRIK2 Q13002 1/20 0.32
GRM1 Q13255 1/20 0.32
GRM2 Q14416 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
ABCC4 O15439 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2392849 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL982293 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL8624374 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL6858104 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL6862064 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL2770074 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL6865841 1.00 TBXAS1 (0.43) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL2008693 0.98 TBXAS1 (0.41) TBXAS1LMNATSHRNFKB1PMP22
SCHEMBL449324 0.90
SCHEMBL1860769 0.87 TBXAS1 (0.50) TBXAS1LMNATSHRNFKB1PMP22

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1242516-B1 PREPARATION OF FUNCTIONAL POLYMERIC SURFACE COMMW SCIENT IND RES ORG (AU) 2004-08-25 EP claimed
US-10590218-B2 Polymer compositions with enhanced radiopacity ENDOSHAPE, INC. (US) 2020-03-17 US disclosed
EP-2968620-B1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY ENDOSHAPE INC (US) 2019-02-13 EP disclosed
US-20160024239-A1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY EMBOLIZATION, INC. 2016-01-28 US disclosed
EP-2968620-A1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY Endoshape, Inc. (US) 2016-01-20 EP disclosed
WO-2014200594-A1 POLYMER COMPOSITIONS WITH ENHANCED RADIOPACITY ENDOSHAPE, INC. (US) 2014-12-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10590218-B2 Polymer compositions with enhanced radiopacity PARN, PARG, RAD50 TBXAS1 2363/4885LMNA 1418/4885TSHR 4094/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.